Screening for Addison's disease in patients with type 1 diabetes mellitus and recurrent hypoglycaemia

Postgraduate Medical Journal

Volumn 83, Issue 980, 2007, Pages 420-421

  Likhari, Taruna ^a   Magzoub, Saeed ^a   Griffiths, Melanie J ^a   Buch, Harit N ^a,b   Gama, R ^a  

^a NEW CROSS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TETRACOSACTIDE;

ADDISON DISEASE; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RECURRENT DISEASE;

ADDISON DISEASE; ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; MALE; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 34250781028     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2007.058321     Document Type: Article

References (17)

1. Hardy KJ, Burge MR, Boyle PJ, et al. A treatable cause of recurrent severe hypoglycaemia. Diabetes Care 1994;17:722-4.
2. Phornphutkul C, Boney CM, Gruppuso PA. A novel presentation of Addison disease: hypoglycemia unawareness in an adolescent with insulin-dependent diabetes mellitus. J Pediatr 1998;132:882-4.
3. Armstrong L, Bell PM. Lesson of the week: Addison's disease presenting as reduced insulin requirement in insulin dependent diabetes. BMJ 1996;312:1601-2.
4. McAulay V, Frier BM. Addison's disease in type 1 diabetes presenting with recurrent hypoglycaemia. Postgrad Med J 2000;76:230-2.
5. Thomas JB, Petrovsky N, AmbTer GR. Addison's disease presenting in four adolescents with type 1 diabetes. Pediatr Diabetes 2004;5:207-11.
6. Sakane N, Yoshida T, Yoshioka K, et al. Severe hypoglycaemia and type 1 diabetes with isolated ACTH deficiency. Diabetes Care 1995;18:1621-2.
7. Schroter W, Arends J, Runte L, et al. Hypoglycemia with loss of consciousness during insulin therapy as an initial symptom of Addison's disease. Report of 2 cases. Dtsch Med Wochenschr 1985;110:840-2.
8. Gill GV, Williams G. Causes and management of poor metabolic control. In: Pickup JC, Williams G, eds. Textbook of diabetes, 3rd ed. Oxford: Blackwell Science Ltd, 2006:43.21-38.
9. Dorin RI, Quails CR, Crapo LM. Diagnosis of adrenal insufficiency. Ann Intern Med 2003;139:194-204.
10. Zelissen PM, Bast FJ, Croughs PJ. Associated autoimmunity in Addison's disease. J Autoimmun 1995;8:121-30.
11. Barker JM, Yu J, Yu L, et al. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care 2005;28:850-5.
12. Barker JM, Ide A, Hostetler C, et al. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population. J Clin Endocrinol Metab 2005;90:128-34.
13. Papadopoulos KI, Hallengren B. Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease. Acta Endocrinol (Copenhagen) 1990;122:472-8.
14. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004;350:2068-79.
15. Orth DN, Kovacs WJ. The adrenal cortex. In: Wilson JW, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology, 9th ed. Philadelphia: WB Saunders, 1998:517-664.
16. Le Roux CW, Meeran K, Alaghband-Zadeh J. Is a 09. 00-h serum Cortisol useful prior to a short synacthen in outpatient assessment Ann Clin Biochem, 2002;39:148-50.
17. Leong KS, Wallymahmed M, Wilding J, et al. Clinical presentation of thyroid dysfunction and Addison's disease in young adults with type 1 diabetes. Postgrad Med J 1999;75:467-70.